Dáil Éireann Debate, Thursday - 13 July 2017
646. Deputy Billy Kelleher asked the Minister for Health if he will report on the development and implementation of performance metrics for all hepatitis C treatment sites to drive treatment volume and monitor performance. [33922/17]
View answer647. Deputy Billy Kelleher asked the Minister for Health if strategies for the continued identification of hepatitis C patients for treatment and development of pathways to care have been devised; and if so, the details of same. [33923/17]
View answer648. Deputy Billy Kelleher asked the Minister for Health the status of the review of the prioritisation and selection criteria of patients for treatment through the national hepatitis C treatment programme clinical advisory group. [33924/17]
View answer649. Deputy Billy Kelleher asked the Minister for Health if he will report on the development of the hepatitis C registry to support continued planning of treatment for the duration of the national hepatitis C treatment programme. [33925/17]
View answer650. Deputy Billy Kelleher asked the Minister for Health if he will report on the development of the hepatitis C registry to support the provision of clinical information on patient outcomes to the national hepatitis C treatment programme. [33926/17]
View answer651. Deputy Billy Kelleher asked the Minister for Health if he will report on the development and implementation of improved infrastructural support to the hepatitis C registry. [33927/17]
View answerI propose to take Questions Nos. 646 to 651, inclusive, together.
As these are service matters, they have been referred to the Health Service Executive for attention and direct reply to the Deputy.
